BRTX — Biorestorative Therapies Share News
0.000.00%
Last trade - 00:00- $2.24m
- -$1.35m
- $0.36m
BioRestorative Therapies Inc expected to post a loss of $2.50 a share - Earnings Preview
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
BioRestorative Therapies Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Biorestorative Therapies Announces Reverse Stock Split
BioRestorative Therapies Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Biorestorative Therapies Suspends All Orders, Shipments Of Exocr, Biox Biocosmeceutical Product Lines Effective Immediately, On Aug 7
BioRestorative Therapies Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Biorestorative Therapies - Lance Alstodt Resigns As President, CEO, Chairman And All Other Positions Effective July 13, 2026 - SEC Filing
Brief: Kaos Capital Acquires 4.9% Stake In Biorestorative Therapies
Brief: Biorestorative Therapies Says Topline Phase 2 Data For BRTX-100 Expected In Q2 2027
Brief: Biorestorative Therapies' BRTX-100 Shows Sustained Pain & Functional Improvements In Chronic Lumbar Disc Disease
Brief: Biorestorative Therapies Reports Positive Phase 2 Blinded Data For Brtx-100
Brief: Biorestorative Expands Global Protection For Thermostem
Brief: BioRestorative Announces Pricing Of $5.0 Million Public Offering
Brief: Biorestorative Announces Positive Outcome From Type B Meeting With FDA